Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Just add the original purchase price of the 3MM shares - their initial investment, and you’ll have their side pretty well reflected.
May the fourth
be with you
I believe the data can be shared with a NDA...can’t be shared publicly.
Checked with a different friend who also should know and asked if BP had different filing requirements and he said “shouldn’t be...public is public, US listed?”
I know somebody who should know this...a J&J Division CFO...I’ll try to find out on Sunday.
I considered that too Iggy; specifically about where the Offered Shares landed (Blue.)
There was news to report in 16, not in 17.
Hov, the speculation is not baseless; it may be off by a mile, but clearly it’s not baseless.
True but, no offense Catt, right now we have slightly better than, “it’s true, I read it on the internet.”
“We absolutely had to do the offering to avoid going concern designation, and since we were so far along in negotiations with our new controlling partner, chose to offer those shares directly to Amgen.”
From the future press release
Come on Big Tony...just want to hear two words on Monday morning..."Mission Accomplished!" for real this time.
So Hare is missing right after Easter weekend?
Tom Moore drove a Chrysler. Saw that one morning when I was waiting in the parking lot for DOC to arrive for my 9am meeting (June, 2013).
In a Non-Change of Control scenario, there is only one way to definitively state:
"The New CEO will be on-Board in the first Half."
That one way to know this for sure is if an offer has already been extended AND accepted. Otherwise Tony would not have made that definitive statement, he would have said something like "we are targeting having a new CEO/CMO by June 30th," or something similar.
So, still in a Non-Change of Control scenario, if an offer has been offered and accepted...What would be the purpose of waiting? Only one, complete a deal and bring the new CEO on board.
Either a Change in control is happening soon, or the ink is drying on the deal.
Speaking of "Prized Dairy Cows," Elsie the Cow is buried near Grover's Mill, and a very short drive from Advaxis HQ.
DOC worked at Bracco too. They must excel in the art of the elevator speech.
Mortmann,
Not sure if you realize just how funny this is. Advaxis HQ is just a few miles from Grover’s Mill of Orson Welles fame. If you’re not familiar with it, you can look it up.
The truth is out there,
Donja
Seems like a no-brainer at this point, albeit in hindsight.
All the Jersey boys who got on NJ Transit to attend the Board meeting in NYC....can’t you get in your car and do a drive by on College Rd?
These aren’t impulse purchases. The decision was made some time last Fall to regularly buy at Market prices. No issue with insider purchase rules. No “tell” about nothing in process either.
Oh just put out a PR and say “We’re in a quiet period.”
James, you sly devil.
She is not returning messages on this issue. She is not traveling outside of the country. She enjoyed a beautiful Easter with her beautiful family in (ahem) beautiful New Joysey. If she wanted to kill this rumor, (we all know Advaxis management reads the message boards) she could return a single phone call.
So you think they made a cosmetic change on the website for "public perception" and waited until the stock was below $2 to do so ? Seems like as big a stretch as the other assumptions related to this matter.
Thoughts/ramblings; unraveling the unknown...
1. Senior executives are usually the ones let go when companies are trying to save money (very high Executive Pay and long-term Equity awards)...But Advaxis doesn't give a flying cluck about exec pay Equity dilution (or cashflow despite Bonstein's delusional drivel) so this really doesn't seem to me like a short term savings strategy.
2. Two of the Senior positions removed are critical for Advaxis as a an independent company particularly Regulatory VP and COO position. Removing them, and doing so all at once, appears to be a signal that either New Leadership (CEO wanting to build own team) or change in control is coming. The former (a CEO wanting his/her own team) wouldn't likely manifest as ALL five folks being removed. Frankly a CFO is a position that a CEO likes to have hiring input in as that working relationship is important (Bonstein was brought in by DOC)...If two or three were removed the idea that a new CEO is bringing some new people in seems more plausible than the entire team (unless DOC's hiring skills were as awful as his stock price prediction skills.) Petit preceded O'Connor at Advaxis and he is the Star.
3. Bonstein was given a retention bonus and is still there because they NEED A CFO right now (for all we know new retention bonuses have been given to Petit and Bonstein through September 2018...we won't find out until we see it filed months from now.)...
4. While the clinical hold seems to have more than one event on hold, the real critical event that was holding things up was the official passing of the 30MM shares - I think a partial buyout by Amgen (as predicted by Iggy) looks likely.
It gives the illusion of open input...unless you are the person who had your comment censored...
If we see $30 Cornflakes is buying a Yacht and hosting all of us on a week long tropical cruise. I hope he invites me.
Haha, Hornet referenced "Orwelian" behavior erasing people from the website and now this...
Cornflakes can’t accept these as a viable solutions because his warrants expire in October. If the powers that be gave Cornflakes the option of Advaxis selling for $0.5B in July, 2018 or $3.5B in a July, 2019 he would choose the former 10 times out of 10.
The long nightmare may be concluding my friend.
Fat Elvis or Skinny Elvis?
That Robert Ashworth is a completely different human being. Been with Amgen for 15 months.
Not clear Mypeke...linked in still showing advaxis.
If they provide any details it will only be whether or not the individuals are still employed at the company. That's all they will say.
Looks like a plausible scenario Iggy. $2 ransom payment will be justified as done prior to knowing how Shareholder vote would go.
Maybe partial buyout by Amgen. Needed the 30MM shares to make it happen? After shareholder vote they took first step of clearing execs not needed. Amgen will bring in CEO and CMO...
Warrant holders are offering ideas they believe can move the share price in the immediate short-term because they are holding expiring assets that will be worthless in October otherwise.
The rationale is "If the true value of the company will take more than 6 months to manifest, you must do what I want you to do right now to move the short term price." Right now warrant holders believe the Short Term price is the most important thing; more important than the long term prospects of the company.
Warrant holders are basically carpet baggers. They do not own equity in the company. They want to profit off of the company without being an owner (To be clear, I love warrants, options and even shorting because generally these bring liquidity). Buying a warrant is a trader strategy not an investment strategy. The long term possibilities of this company are not important to them as the warrant expiration date approaches.
Yeah, these proposals always pass because the Broker Non-Votes always push the resolutions over.
Going from memory...A primary reason DOC's Very First Advaxis * Proxy passed in '13 was on the last revision of the Proxy (there were maybe five? six? revisions...) there was a change to how the votes for the R/S would be counted FROM "Only votes approving the R/S cast by shareholders themselves TO Shareholder votes Plus Broker Non-Votes (allowing Brokers to vote the measure for any shareholders that do not vote themselves, which is always most.) The Brokers always vote for the BOD suggestions. First x number of versions were shareholders only. Final revision allowed BNV to count towards approval of R/S. It was done without calling any attention to the change...in the fine print of the proxy.
* DOC's First Advaxis Proxy was the one that authorized the R/S and also provided the authorized shares for the initial capital raise...but removed a Management Comp proposal because on Dan's personal shareholder call arounds he knew he didn't have the votes AND also Cut Dramatically the Original Authorized Shares Request (shareholders voting today on the 30MM shares may not know DOC tried to originally get (I think it was) 150MM shares authorized on his first proxy but got squashed down on his phone calls to shareholders.
Exactly and that is also why BNV will carry the vote to approval again.
No surprises